Debra Hanna, PhD, Associate Director Critical Path to TB Drug Regimens Regulatory Science Consortium Critical Path Institute Wednesday, March 21, 2012 4 p.m. - 5 p.m. Mel and Enid Zuckerman College of Public Health Drachman Hall, Room A114

In recognition of World TB Day the UA College of Public Health presents…

Tuberculosis: The Critical Path to Developing a Cure, March 21st

Tuberculosis (TB) is often thought to be a disease of the past.

The reality: Because no new therapies for TB have been developed in the past 50 years and treatment is long and complex, TB continues to kill 1.4 million people a year—someone every 20 seconds. Additionally, drug resistant forms of TB are an imminent public health concern.

In recognition of World TB Day, Dr. Debra Hanna will talk about the current global and local status of this disease and the vital work the Critical Path to TB Regimens initiative is doing to advance new, better, and faster-acting combination TB drug regimens. This effort is the result of an unprecedented collaboration among public and private partners around the world.